Summit Therapeutics stockholders approve all proposals at 2025 annual meeting

Summit Therapeutics Inc.

All nine director nominees elected (Duggan, Zanganeh, Soni, Clark, Booth, Cesano, Xia, Ronaghi, Huber) with >98% support.
Ratification of PwC as independent auditor for FY2025 approved: 653,328,708 for, 195,007 against, 233,629 abstain.
Non-binding say-on-pay resolution approved: 607,320,353 for, 16,607,648 against, 177,556 abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.